tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ALIM Stock Latest News

Alimera Sciences downgraded to Neutral from Buy at Alliance Global Partners
The FlyAlimera Sciences downgraded to Neutral from Buy at Alliance Global Partners
8d ago
ALIM
Alimera Sciences downgraded to Hold from Buy at Maxim
PremiumThe Fly
Alimera Sciences downgraded to Hold from Buy at Maxim
8d ago
ALIM
Alimera Sciences downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Alimera Sciences downgraded to Neutral from Buy at H.C. Wainwright
8d ago
ALIM
Alimera Sciences downgraded to Hold from Buy at Craig-Hallum
PremiumThe Fly
Alimera Sciences downgraded to Hold from Buy at Craig-Hallum
9d ago
ALIM
Alimera Sciences Set for Merger with ANI Pharmaceuticals
PremiumCompany Announcements
Alimera Sciences Set for Merger with ANI Pharmaceuticals
9d ago
8K
ALIM
ANI Pharmaceuticals sees ‘substantial accretion’ from Alimera Sciences deal
PremiumThe FlyANI Pharmaceuticals sees ‘substantial accretion’ from Alimera Sciences deal
9d ago
ALIM
ANIP
ANI Pharmaceuticals to acquire Alimera Sciences for $381M upfront
PremiumThe Fly
ANI Pharmaceuticals to acquire Alimera Sciences for $381M upfront
9d ago
ALIM
ANIP
Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
29d ago
ALIM
Alimera Sciences reports Q1 EPS (12c), consensus (6c)
PremiumThe Fly
Alimera Sciences reports Q1 EPS (12c), consensus (6c)
2M ago
ALIM
Alimera Sciences Reports First Quarter 2024 Results
PremiumPress Releases
Alimera Sciences Reports First Quarter 2024 Results
2M ago
ALIM
ALIM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
ALIM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
ALIM
Alimera Sciences initiated with a Buy at Maxim
PremiumThe Fly
Alimera Sciences initiated with a Buy at Maxim
3M ago
ALIM
Alimera Sciences reports inducement grants under Nasdaq listing rule
PremiumThe FlyAlimera Sciences reports inducement grants under Nasdaq listing rule
4M ago
ALIM
Alimera announces first patient randomized in radiation retinopathy trial
PremiumThe Fly
Alimera announces first patient randomized in radiation retinopathy trial
4M ago
ALIM
Alimera Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina Network
PremiumPress Releases
Alimera Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina Network
4M ago
ALIM
Alimera Sciences price target raised to $6 from $5 at H.C. Wainwright
PremiumThe Fly
Alimera Sciences price target raised to $6 from $5 at H.C. Wainwright
4M ago
ALIM
Alimera Sciences Reports Fourth Quarter and Full Year 2023 Results
PremiumPress Releases
Alimera Sciences Reports Fourth Quarter and Full Year 2023 Results
4M ago
ALIM
Alimera Sciences reports Q4 EPS (7c) vs (54c) last year
PremiumThe Fly
Alimera Sciences reports Q4 EPS (7c) vs (54c) last year
4M ago
ALIM
Alimera Sciences (ALIM) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Alimera Sciences (ALIM) Q4 Earnings Cheat Sheet
5M ago
ALIM
Alimera Sciences Launches 2024 Equity Inducement Plan
PremiumCompany AnnouncementsAlimera Sciences Launches 2024 Equity Inducement Plan
5M ago
8K
ALIM
The UK National Institute for Health and Care Excellence (NICE) Issues Final Draft Guidance to Provide Patients with a Natural Lens (Phakic Eye) Being Treated for Chronic Diabetic Macular Edema Access to ILUVIEN®
PremiumPress Releases
The UK National Institute for Health and Care Excellence (NICE) Issues Final Draft Guidance to Provide Patients with a Natural Lens (Phakic Eye) Being Treated for Chronic Diabetic Macular Edema Access to ILUVIEN®
5M ago
ALIM
Alimera announces NICE issued Final Draft Guidance on ILUVIEN
PremiumThe Fly
Alimera announces NICE issued Final Draft Guidance on ILUVIEN
5M ago
ALIM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >